Literature DB >> 1883394

Effects of androgen on intracellular calcium of LNCaP cells.

J Steinsapir1, R Socci, P Reinach.   

Abstract

Mibolerone (dimethylnortestosterone) or 5 alpha-dihydrostestosterone (DHT) increase intracellular calcium (Ca2+i) of human prostate cancer cells (LNCaP) as early as 2 min after treatment. These effects were concentration-dependent (10(-6)-10(-12) M) and they were blocked by preincubation with hydroxyflutamide (10(-6) M). Verapamil (10(-6) M) also suppressed the mibolerone (10(-6) M)-induced increase in Ca2+i, in cells which were previously exposed to 1 mM CaCl2 introduced in a Ca(2+)-free media. The results indicate that androgens elicit changes in Ca2+i in LNCaP cells as a result of Ca2+ influx through L-type channels in the plasma membrane. Since androgens are involved in the regulation of prostate cell division and growth, these findings suggest that calcium is involved in metabolic and mitogenic responses to steroid hormone in target cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883394     DOI: 10.1016/0006-291x(91)91338-d

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Oxidative stress defines the neuroprotective or neurotoxic properties of androgens in immortalized female rat dopaminergic neuronal cells.

Authors:  Shaletha Holmes; Babak Abbassi; Chang Su; Meharvan Singh; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2013-08-19       Impact factor: 4.736

2.  The vasodilatory effect of testosterone on renal afferent arterioles.

Authors:  Yan Lu; Yiling Fu; Ying Ge; Luis A Juncos; Jane F Reckelhoff; Ruisheng Liu
Journal:  Gend Med       Date:  2012-03-22

3.  Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro.

Authors:  M E Laniado; E N Lalani; S P Fraser; J A Grimes; G Bhangal; M B Djamgoz; P D Abel
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

4.  A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.

Authors:  Loukia G Karacosta; Barbara A Foster; Gissou Azabdaftari; David M Feliciano; Arthur M Edelman
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

5.  Testosterone activates mitogen-activated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells.

Authors:  Charity Fix; Cynthia Jordan; Patricia Cano; William H Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

6.  A novel androgen signalling pathway uses dihydrotestosterone, but not testosterone, to activate the EGF receptor signalling cascade in prostate stromal cells.

Authors:  V L Oliver; K Poulios; S Ventura; J M Haynes
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

Review 7.  Non-genomic actions of androgens.

Authors:  C D Foradori; M J Weiser; R J Handa
Journal:  Front Neuroendocrinol       Date:  2007-11-07       Impact factor: 8.606

Review 8.  Classical androgen receptors in non-classical sites in the brain.

Authors:  Sara Sarkey; Iñigo Azcoitia; Luis Miguel Garcia-Segura; Daniel Garcia-Ovejero; Lydia L DonCarlos
Journal:  Horm Behav       Date:  2008-03-06       Impact factor: 3.587

9.  Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation.

Authors:  Zbigniew P Kortylewicz; Jessica Nearman; Janina Baranowska-Kortylewicz
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

Review 10.  Vascular Pathways of Testosterone: Clinical Implications.

Authors:  Margarida Lorigo; Melissa Mariana; Nelson Oliveira; Manuel C Lemos; Elisa Cairrao
Journal:  J Cardiovasc Transl Res       Date:  2019-12-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.